OCT Biomarkers as Functional Outcome Predictors in Diabetic Macular Edema Treated with Dexamethasone Implant
© 2017 American Academy of Ophthalmology Purpose: Identification and characterization of patients with diabetic macular edema (DME) are important for individualizing treatment and optimizing outcome. We investigated OCT biomarkers for DME treated by intravitreal dexamethasone (DEX) implant. Design:...
Saved in:
Main Authors: | Dinah Zur, Matias Iglicki, Catharina Busch, Alessandro Invernizzi, Miriana Mariussi, Anat Loewenstein, Zafer Cebeci, Jay Kumar Chhablani, Voraporn Chaikitmongkol, Aude Couturier, Samantha Fraser-Bell, Ermete Giancipoli, Inês Laíns, Marco Lupidi, Matus Rehak, Patricio Rodriguez, Thais Sousa Mendes, Anna Sala-Puigdollers |
---|---|
Format: | Journal |
Published: |
2018
|
Subjects: | |
Online Access: | https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85029469469&origin=inward http://cmuir.cmu.ac.th/jspui/handle/6653943832/59003 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Chiang Mai University |
Similar Items
-
Disorganization of retinal inner layers as a biomarker in patients with diabetic macular oedema treated with dexamethasone implant
by: Dinah Zur, et al.
Published: (2019) -
DEXAMETHASONE IMPLANT FOR DIABETIC MACULAR EDEMA IN NAIVE COMPARED WITH REFRACTORY EYES: The International Retina Group Real-Life 24-Month Multicenter Study. The IRGREL-DEX Study
by: Matias Iglicki, et al.
Published: (2019) -
Causative Pathogens of Endophthalmitis after Intravitreal Anti-VEGF Injection: An International Multicenter Study
by: Catharina Busch, et al.
Published: (2019) -
Shall we stay, or shall we switch? Continued anti-VEGF therapy versus early switch to dexamethasone implant in refractory diabetic macular edema
by: Catharina Busch, et al.
Published: (2018) -
Baseline predictors for visual acuity loss during observation in diabetic macular oedema with good baseline visual acuity
by: Catharina Busch, et al.
Published: (2020)